Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Mohammad A. Rai, Sam Pannek & Carl J. Fichtenbaum. (2018) Emerging reverse transcriptase inhibitors for HIV-1 infection. Expert Opinion on Emerging Drugs 23:2, pages 149-157.
Read now
Read now
M. Crespo, J. Navarro, M. Martinez-Rebollar, D. Podzamczer, P. Domingo, J. Mallolas, M. Saumoy, G. M. Mateo, A. Curran, J. Gatell & E. Ribera. (2016) Improvement of BMD after Switching from Lopinavir/R Plus Two Nucleos(T)ide Reverse Transcriptase Inhibitors to Lopinavir/R Plus Lamivudine: OLE-LIP Substudy. HIV Clinical Trials 17:3, pages 89-95.
Read now
Read now
Pablo Barreiro, José Vicente Fernández-Montero, Carmen de Mendoza, Pablo Labarga & Vincent Soriano. (2014) Pharmacogenetics of antiretroviral therapy. Expert Opinion on Drug Metabolism & Toxicology 10:8, pages 1119-1130.
Read now
Read now
Articles from other publishers (19)
Li Li, Jing Zhao, Shi Qi & Dechun Li. 2022. Radiology of Infectious and Inflammatory Diseases - Volume 5. Radiology of Infectious and Inflammatory Diseases - Volume 5
217
233
.
Roberto Pacifici, L. Lawenius, K. Sjögren & Claes Ohlsson. 2021. Marcus and Feldman's Osteoporosis. Marcus and Feldman's Osteoporosis
969
988
.
Jasmijn FaberAnneke BechPetra van BentumJet GisolfRobert-Jan HassingHans de Boer. (2020)
Long-Term Impact of Calcium and Vitamin D Supplementation on Bone Density in HIV
+
Patients with Documented Deficiencies
. AIDS Research and Human Retroviruses 36:1, pages 58-64.
Crossref
Crossref
Hwa‐Ping Feng, Zifang Guo, Luzelena Caro, Jennifer E. Talaty, Eric Mangin, Deborah Panebianco, Christine Fandozzi, Yali Zhu, William Marshall, Xiaobi Huang, William D. Hanley, Patricia Jumes, Robert Valesky, Monika Martinho, Joan R. Butterton, Marian Iwamoto & Wendy W. Yeh. (2019) Assessment of Drug Interaction Potential Between the Hepatitis C Virus Direct‐Acting Antiviral Agents Elbasvir/Grazoprevir and the Nucleotide Analog Reverse‐Transcriptase Inhibitor Tenofovir Disoproxil Fumarate. Clinical Pharmacology in Drug Development 8:7, pages 962-970.
Crossref
Crossref
Julie J. Kim-ChangLorena WilsonCliburn ChanBernard FischerGuglielmo VenturiMaureen M. GoodenowGrace AldrovandiThomas J. WeberJohn W. Sleasman Emmanuel, Lujan-Zilberman, Julian, Belzer, Flores, Tucker, Kovacs, Homans, Lozano, D'Angelo, Hagler, Trexler, Douglas, Tanney, DiBenedetto, Martinez, Bojan, Jackson, Febo, Ayala-Flores, Fuentes-Gomez, Futterman, Enriquez-Bruce, Campos, Steever, Geiger, Moscicki, Auerswald, Irish, Abdalian, Kozina, Baker, Peralta, Gorle, Friedman, Maturo, Major-Wilson, Puga, Leonard, Inman, Flynn, Dillard, Garofalo, Brennan & Flanagan. (2019) Tenofovir Has Minimal Effect on Biomarkers of Bone Health in Youth with HIV Receiving Initial Antiretroviral Therapy. AIDS Research and Human Retroviruses 35:8, pages 746-754.
Crossref
Crossref
Hao Liu, Ranli Gu, Wei Li, Wen Zhou, Zhe Cong, Jing Xue, Yunsong Liu, Qiang Wei & Yongsheng Zhou. (2019)
Lactobacillus rhamnosus
GG attenuates tenofovir disoproxil fumarate-induced bone loss in male mice
via
gut-microbiota-dependent anti-inflammation
. Therapeutic Advances in Chronic Disease 10, pages 204062231986065.
Crossref
Crossref
F. S. Mirza, P. Luthra & L. Chirch. (2018) Endocrinological aspects of HIV infection. Journal of Endocrinological Investigation 41:8, pages 881-899.
Crossref
Crossref
Anita Chawla, Christina Wang, Cody Patton, Miranda Murray, Yogesh Punekar, Annemiek de Ruiter & Corklin Steinhart. (2018) A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population. Infectious Diseases and Therapy 7:2, pages 183-195.
Crossref
Crossref
Peter L Havens, Charles B Stephensen, Marta D Van Loan, Gertrud U Schuster, Leslie R Woodhouse, Patricia M Flynn, Catherine M Gordon, Cynthia G Pan, Brandy Rutledge, D Robert Harris, Georgine Price, Alyne Baker, William A MeyerIIIIII, Craig M Wilson, Rohan Hazra, Bill G Kapogiannis, Kathleen Mulligan, Kavya Vellala, Justin Wheeler, Roger Fielding, Tammy Freytag, Joseph Domek, Erik Gertz, Patricia Emmanuel, Diane Straub, Elizabeth Enriquez-Bruce, Marvin Belzer, Diane Tucker, Larry D’Angelo, Connie Trexler, Steve Douglas, Mary Tanney, John H StrogerJr.Jr., Miguel Martinez, Lisa Henry-Reid, Kelly Bojan, Donna Futterman, Maria Campos, Sue Ellen Abdalian, Leslie Kozina, Larry Friedman, Donna Maturo, Pat Flynn, Aditya Guar, Mary Dillard, Mary Paul, Jane Head, Liz Secord, Angulique Outlaw, Charnell Cromer, Allison Agwu, Renata Sanders, Thuy Anderson, Ken Mayer, Julian Dormitzer, Dan Reirden, Carrie Chambers, Andrea Kovacs, Eva Operskalski, James Homans, Allison Bearden, Susie Sanchez, Ana Puga, Zulma Eysallenne, Midnela Acevedo, Nicolas Rosario, Lourdes Angeli Nieves, Andrew Wiznia, Jacobo Abadi, Michael Rosenberg, Joanna Dobroszycki & Marlene Burey. (2018) Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial. Clinical Infectious Diseases 66:2, pages 220-228.
Crossref
Crossref
Caitlin A. Moran, M. Neale Weitzmann & Ighovwerha Ofotokun. (2017) Bone Loss in HIV Infection. Current Treatment Options in Infectious Diseases 9:1, pages 52-67.
Crossref
Crossref
James M Mikula, Maura M Manion, Frank Maldarelli, Lucila M Suarez, Jaha F Norman-Wheeler, Alex G Ober, Robin L Dewar, Jeffrey B Kopp, H Clifford Lane & Alice K Pau. (2015) Tenofovir Alafenamide as Part of a Salvage Regimen in a Patient with Multi-Drug Resistant HIV and Tenofovir-DF-Associated Renal Tubulopathy. Antiviral Therapy 21:6, pages 553-558.
Crossref
Crossref
Mohamed G. Atta, Michelle M. Estrella, Derek M. Fine, Katie Zook, Jose Manuel Monroy Trujillo, James H. Stein & Gregory M. Lucas. (2016) Correlates and Longitudinal Renal and Cardiovascular Implications of FGF23 Levels in HIV-Positive Individuals. PLOS ONE 11:5, pages e0155312.
Crossref
Crossref
Lisa Hamzah, Juan M Tiraboschi, Helen Iveson, Martina Toby, Christine Mant, John Cason, Keith Burling, Emily Wandolo, Isabelle Jendrulek, Chris Taylor, Fowzia Ibrahim, Ranjababu Kulasegaram, Alastair Teague, Frank A Post & Julie Fox. (2015) Effects on Vitamin D, Bone and the Kidney of Switching from Fixed-Dose Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz to Darunavir/ Ritonavir Monotherapy: A Randomized, Controlled Trial (MIDAS). Antiviral Therapy 21:4, pages 287-296.
Crossref
Crossref
J Young, I Mucsi, KC Rollet-Kurhajec & MB Klein. (2016) Fibroblast growth factor 23: associations with antiretroviral therapy in patients co-infected with HIV and hepatitis C. HIV Medicine 17:5, pages 373-379.
Crossref
Crossref
Caitlin A. Moran, M. Neale Weitzmann & Ighovwerha Ofotokun. (2016) The protease inhibitors and HIV-associated bone loss. Current Opinion in HIV and AIDS 11:3, pages 333-342.
Crossref
Crossref
. (2015) Documento de consenso de GeSIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos con infección por el virus de la inmunodeficiencia humana (Actualización enero 2015). Enfermedades Infecciosas y Microbiología Clínica 33:8, pages 543.e1-543.e43.
Crossref
Crossref
Vincenzo Esposito, Angelica Perna, Angela Lucariello, Maria Aurora Carleo, Rosaria Viglietti, Vincenzo Sangiovanni, Nicola Coppola, Germano Guerra, Antonio De Luca & Antonio Chirianni. (2015) Different Impact Of Antiretroviral Drugs On Bone Differentiation In An In Vitro Model. Journal of Cellular Biochemistry 116:10, pages 2188-2194.
Crossref
Crossref
Alice K. Pau & Jomy M. George. (2014) Antiretroviral Therapy. Infectious Disease Clinics of North America 28:3, pages 371-402.
Crossref
Crossref
. (2014) Documento de consenso de GeSIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (Actualización enero 2014). Enfermedades Infecciosas y Microbiología Clínica 32:7, pages 446.e1-446.e42.
Crossref
Crossref